• 529 Citations
  • 13 h-Index
20012020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2005 Ph.D. (Pharmaceutics), School of Pharmacy, The Ohio State University, USA
  • 1998 M.S., (Pharmacy) National Taiwan University
  • 1996 B.S., School of Pharmacy, National Taiwan University

Experience

  • 2016- 臺北醫學大學藥物科學學科副教授
  • 2013- 臺北醫學大學中草藥臨床藥物研發博士學位學程
  • 2012-2016 臺北醫學大學藥物科學學科助理教授
  • 2006-2012 臺北醫學大學藥學系助理教授

Research Interests

  • Delivery of gene/siRNA/antisense agents by nanoparticles or liposomes
  • Targeted drug/gene/antisense delivery systems
  • Nanoparticle design and synthesis
  • Development of novel biomaterials for drug/gene/antisense delivery

Fingerprint Dive into the research topics where Shih-Jiuan Chiu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Development of Multifunctionalized Nanoparticles for Delivery of Chemotherapeutic Agents to Triple-Negative Breast Cancer

Chiu, S.

8/1/197/31/20

Project: A - Government Institutionb - Ministry of Science and Technology

Multifunctional Nanoparticles for Cancer Therapy

Chiu, S.

8/1/157/31/16

Project: A - Government Institutionb - Ministry of Science and Technology

Simultaneous Delivery of an Antisense Oligonucleotide and a Chemotherapeutic Agent by a Her2-Targeted Liposomal System

Chiu, S.

8/1/127/31/13

Project: A - Government Institutionb - Ministry of Science and Technology

Simultaneous Delivery of an Antisense Oligonucleotide and a Chemotherapeutic Agent by a Her2-Targeted Liposomal System

Chiu, S.

8/1/117/31/12

Project: A - Government Institutionb - Ministry of Science and Technology

Research Output

  • 529 Citations
  • 13 h-Index
  • 28 Article
  • 1 Chapter
  • 1 Comment/debate
Open Access
  • Divaricoside Exerts Antitumor Effects, in Part, by Modulating Mcl-1 in Human Oral Squamous Cell Carcinoma Cells

    Weng, J. R., Bai, L. Y., Chiu, S. J., Chiu, C. F., Lin, W. Y., Hu, J. L. & Shieh, T. M., Jan 1 2019, In : Computational and Structural Biotechnology Journal. 17, p. 151-159 9 p.

    Research output: Contribution to journalArticle

  • 3 Citations (Scopus)

    A 5' AMP-Activated Protein Kinase Enzyme Activator, Compound 59, Induces Autophagy and Apoptosis in Human Oral Squamous Cell Carcinoma

    Weng, J. R., Dokla, E. M. E., Bai, L. Y., Chen, C. S., Chiu, S. J. & Shieh, T. M., Jan 1 2018, (Accepted/In press) In : Basic and Clinical Pharmacology and Toxicology.

    Research output: Contribution to journalArticle

  • 3 Citations (Scopus)

    Formation of organosilica nanoparticles with dual functional groups and simultaneous payload entrapment

    Su, Y. L., Lin, C. Y., Chiu, S. J. & Hu, T. M., May 19 2018, In : Journal of Microencapsulation. 35, 4, p. 381-391 11 p.

    Research output: Contribution to journalArticle

  • 1 Citation (Scopus)

    FTY720 Induces Autophagy-Associated Apoptosis in Human Oral Squamous Carcinoma Cells, in Part, through a Reactive Oxygen Species/Mcl-1-Dependent Mechanism

    Bai, L. Y., Chiu, C. F., Chiu, S. J., Chu, P. C. & Weng, J. R., Dec 1 2017, In : Scientific Reports. 7, 1, 5600.

    Research output: Contribution to journalArticle

  • 19 Citations (Scopus)